Cambrex set to acquire Halo Pharma for $425m to expand into finished dosage form market

In a significant expansion of its capabilities, Cambrex Corporation has announced its agreement to acquire Halo Pharma, a US-based contract development and manufacturing organization (CDMO), ... Read More